Tempus AI (NASDAQ:TEM) Shares Gap Up to $36.60

Tempus AI, Inc. (NASDAQ:TEMGet Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $36.60, but opened at $38.50. Tempus AI shares last traded at $38.28, with a volume of 120,838 shares changing hands.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. William Blair assumed coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They set an “outperform” rating for the company. TD Cowen assumed coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They set a “buy” rating and a $50.00 target price for the company. Loop Capital started coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They set a “buy” rating and a $48.00 target price for the company. Longbow Research started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price target on the stock. Finally, JPMorgan Chase & Co. started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued an “overweight” rating and a $42.00 price target on the stock. Nine research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $45.63.

View Our Latest Analysis on TEM

Tempus AI Stock Up 12.5 %

About Tempus AI

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Recommended Stories

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.